The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Identification of the enzymatic mechanism of nitroglycerin bioactivation
Open accessAbstract
Nitroglycerin (glyceryl trinitrate, GTN), originally manufactured by Alfred Nobel, has been used to treat angina and heart failure for over 130 years. However, the molecular mechanism of GTN biotransformation has remained a mystery and it is not well understood why “tolerance” (i.e., loss of clinical efficacy) manifests over time. Here we purify a nitrate reductase that specifically catalyzes the formation of 1,2-glyceryl dinitrate and nitrite from GTN, leading to production of cGMP and relaxation of vascular smooth muscle both in vitro an d in vivo , and we identify it as mitochondrial aldehyde dehydrogenase (mtALDH). We also show that mtALDH is inhibited in blood vessels made tolerant by GTN. These results demonstrate that the biotransformation of GTN occurs predominantly in mitochondria through a novel reductase action of mtALDH and suggest that nitrite is an obligate intermediate in generation of NO bioactivity. The data also indicate that attenuated biotransformation of GTN by mtALDH underlies the induction of nitrate tolerance. More generally, our studies provide new insights into subcellular processing of NO metabolites and suggest new approaches to generating NO bioactivity and overcoming nitrate tolerance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
Bolotina, V. M., Najibi, S., Palacino, J. J., Pagano, P. J., & Cohen, R. A. (1994) · Nature · doi:10.1038/368850a0 · Cited by 1,691
Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32738-2 · Cited by 1,633
Münzel, T., Sayegh, H., Freeman, B. A., Tarpey, M. M., & Harrison, D. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117637 · Cited by 655
Millar, T. M., Stevens, C. R., Benjamin, N., Eisenthal, R., Harrison, R., & Blake, D. R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00430-x · Cited by 491
Murad, F., Mittal, C. K., Arnold, W. P., Katsuki, S., & Kimura, H. (1978) · PubMed · Cited by 446
Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism
Vasiliou, V., Pappa, A., & Petersen, D. R. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00211-8 · Cited by 390
Kobzik, L., Stringer, B., Balligand, J. L., Reid, M. B., & Stamler, J. S. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1824 · Cited by 376
Self-citationNitrite reductase activity is a novel function of mammalian mitochondria
Kozlov, A. V., Staniek, K., & Nohl, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00788-7 · Cited by 342
Ignarro, L. J., & Gruetter, C. S. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90297-4 · Cited by 316
Cohen, R. A., Weisbrod, R. M., Gericke, M., Yaghoubi, M., Bierl, C., & Bolotina, V. M. (1999) · Circulation Research · doi:10.1161/01.res.84.2.210 · Cited by 297
Research works printed but not linked: 14
- F Murad, C K Mittal, W P Arnold, S Katsuki, H Kimura Adv Cyclic Nucleotide Res 9, 145–158 (1978).
- L J Ignarro, H Lippton, J C Edwards, W H Baricos, A L Hyman, P J Kadowitz, C A Gruetter J Pharmacol Exp Ther 218, 739–749 (1981).
- J F Brien, B E McLaughlin, S M Kobus, J H Kawamoto, K Nakatsu, G S Marks J Pharmacol Exp Ther 244, 322–327 (1988).
- 10.1139/y89-221 · doi:10.1139/y89-221
- R Nigam, D J Anderson, S F Lee, B M Bennett J Pharmacol Exp Ther 279, 1527–1534 (1996).
- T W Dean, D C Baun Am J Hosp Pharm 32, 1036–1038 (1975).
- 10.1016/S0021-9673(01)82416-X · doi:10.1016/s0021-9673(01)82416-x
- J F Brien, B E McLaughlin, T H Breedon, B M Bennett, K Nakatsu, G S Marks J Pharmacol Exp Ther 237, 608–614 (1986).
- 10.1016/S0021-9258(19)45785-2 · doi:10.1016/s0021-9258(19)45785-2
- P Needleman, B Jakschik, E M Johnson J Pharmacol Exp Ther 187, 324–331 (1973).
- E A Kowaluk, S J Chung, H L Fung Drug Metab Dispos 21, 967–969 (1993).
- M Hay Practitioner 30, 422–433 (1883).
- F Brunner, K Schmidt, E B Nielsen, B Mayer J Pharmacol Exp Ther 277, 48–53 (1996).
- P Needleman, F E Hunter Mol Pharmacol 2, 134–143 (1966).
Cited by
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Vascular nitric oxide: Beyond eNOS
Zhao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.09.002 · Cited by 826
Evgenov, O. V., Pacher, P., Schmidt, P. M., Haskó, G., Schmidt, H. H. H. W., & Stasch, J.-P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2038 · Cited by 749
Aldehyde Sources, Metabolism, Molecular Toxicity Mechanisms, and Possible Effects on Human Health
O'Brien, P. J., Siraki, A. G., & Shangari, N. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440591002183 · Cited by 738
Recent developments in nitric oxide donor drugs
Miller, M. R., & Megson, I. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707224 · Cited by 628
Targeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities
Chen, C.-H., Ferreira, J. C. B., Gross, E. R., & Mochly-Rosen, D. (2014) · Physiological Reviews · doi:10.1152/physrev.00017.2013 · Cited by 614
Koppaka, V., Thompson, D. C., Chen, Y., Ellermann, M., Nicolaou, K. C., Juvonen, R. O., Petersen, D., Deitrich, R. A., Hurley, T. D., & Vasiliou, V. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005538 · Cited by 557
Castello, P. R., David, P. S., McClure, T., Crook, Z., & Poyton, R. O. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.011 · Cited by 495
Singel, D. J., & Stamler, J. S. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.060603.090918 · Cited by 481
Self-citationExplaining the Phenomenon of Nitrate Tolerance
Münzel, T., Daiber, A., & Mülsch, A. (2005) · Circulation Research · doi:10.1161/01.res.0000184694.03262.6d · Cited by 424
Münzel, T., Daiber, A., Ullrich, V., & Mülsch, A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168896.64927.bb · Cited by 410
Daiber, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.01.032 · Cited by 347
NO Generation From Nitrite and Its Role in Vascular Control
Lundberg, J. O., & Weitzberg, E. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000161048.72004.c2 · Cited by 341
Dejam, A., Hunter, C. J., Tremonti, C., Pluta, R. M., Hon, Y. Y., Grimes, G., Partovi, K., Pelletier, M. M., Oldfield, E. H., Cannon, R. O., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.712133 · Cited by 334
Egea, J., Fabregat, I., Frapart, Y. M., Ghezzi, P., Görlach, A., Kietzmann, T., Kubaichuk, K., Knaus, U. G., Lopez, M. G., Olaso-Gonzalez, G., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.007 · Cited by 310
Sydow, K., Daiber, A., Oelze, M., Chen, Z., August, M., Wendt, M., Ullrich, V., Mülsch, A., Schulz, E., Keaney, J. F., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419267 · Cited by 300
“The mitochondrial fraction (total protein approximately 3–5 mg/ml) was kept on ice and diluted to approximately increases in production of reactive oxygen species (ROS) (10), and impairment of GTN biotransformation (socalled mechanism-based or classical tolerance) (4).”
BackgroundMethodInfluentialSelf-citationThe SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Steven, S., Oelze, M., Hanf, A., Kröller-Schön, S., Kashani, F., Roohani, S., Welschof, P., Kopp, M., Gödtel-Armbrust, U., Xia, N., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.009 · Cited by 298
Oelze, M., Kröller-Schön, S., Welschof, P., Jansen, T., Hausding, M., Mikhed, Y., Stamm, P., Mader, M., Zinßius, E., Agdauletova, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112394 · Cited by 293
Nitroxyl (HNO): the Cinderella of the nitric oxide story
Irvine, J. C., Ritchie, R. H., Favaloro, J. L., Andrews, K. L., Widdop, R. E., & Kemp-Harper, B. K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.08.005 · Cited by 277
Human aldehyde dehydrogenases: Potential pathological, pharmacological, and toxicological impact
Sládek, N. E. (2003) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10057 · Cited by 266
Discovery of the nitric oxide signaling pathway and targets for drug development
Bryan, N. (2009) · Frontiers in Bioscience · doi:10.2741/3228 · Cited by 254
Vascular system: role of nitric oxide in cardiovascular diseases
Bian, K., Doursout, M., & Murad, F. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.06632.x · Cited by 229
Therapeutic Uses of Inorganic Nitrite and Nitrate: From the Past to the Future
Butler, A. R., & Feelisch, M. (2008) · Circulation · doi:10.1161/circulationaha.107.753814 · Cited by 184
Daiber, A., Oelze, M., Coldewey, M., Bachschmid, M., Wenzel, P., Sydow, K., Wendt, M., Kleschyov, A. L., Stalleicken, D., Ullrich, V., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002600 · Cited by 177
Local delivery of nitric oxide: Targeted delivery of therapeutics to bone and connective tissues
Nichols, S. P., Storm, W. L., Koh, A., & Schoenfisch, M. H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.03.002 · Cited by 148
“For example, nitroglycerin, the most commonly used organic nitrate, primarily “releases” NO upon bioactivation by mitochondrial aldehyde dehydrogenase (mtALDH) [29,30].”
Nitrate-Nitrite-Nitric Oxide Pathway: Implications for Anesthesiology and Intensive Care
Weitzberg, E., Hezel, M., Lundberg, J. O., & Warner, D. S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181fcf3cc · Cited by 145
Nitric oxide and S-nitrosothiols in human blood
Giustarini, D., Milzani, A., Colombo, R., Dalle-Donne, I., & Rossi, R. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00046-9 · Cited by 136
“[38] have recently demonstrated the role of aldehyde dehydrogenase in the onset of tolerance to nitroglycerin.”
BackgroundSayed, N., Kim, D. D., Fioramonti, X., Iwahashi, T., Durán, W. N., & Beuve, A. (2008) · Circulation Research · doi:10.1161/circresaha.108.175133 · Cited by 115
Lim, D. G., Sweeney, S., Bloodsworth, A., White, C. R., Chumley, P. H., Krishna, N. R., Schopfer, F., O'Donnell, V. B., Eiserich, J. P., & Freeman, B. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232409599 · Cited by 110
A comparison of organic and inorganic nitrates/nitrites
Omar, S. A., Artime, E., & Webb, A. J. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.008 · Cited by 106
Knorr, M., Hausding, M., Kröller-Schuhmacher, S., Steven, S., Oelze, M., Heeren, T., Scholz, A., Gori, T., Wenzel, P., Schulz, E., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.232058 · Cited by 100
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential
Scatena, R., Bottoni, P., Martorana, G. E., & Giardina, B. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.835 · Cited by 74
“superoxide); upregulation of phosphodiesterase activity; depletion of thiol equivalents; and recently, dysfunction of mitochondrial aldehyde dehydrogenase [15-20].”
BackgroundLi, H., Liu, X., Cui, H., Chen, Y.-R., Cardounel, A. J., & Zweier, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511803200 · Cited by 74
Kozlov, A. V., Dietrich, B., & Nohl, H. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705323 · Cited by 69
Effect of chronic sodium nitrite therapy on monocrotaline-induced pulmonary hypertension
Pankey, E. A., Badejo, A. M., Casey, D. B., Lasker, G. F., Riehl, R. A., Murthy, S. N., Nossaman, B. D., & Kadowitz, P. J. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.02.004 · Cited by 35
Badejo, A. M., Hodnette, C., Dhaliwal, J. S., Casey, D. B., Pankey, E., Murthy, S. N., Nossaman, B. D., Hyman, A. L., & Kadowitz, P. J. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00959.2009 · Cited by 32
Liu, M., Zollbrecht, C., Peleli, M., Lundberg, J. O., Weitzberg, E., & Carlström, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.025 · Cited by 30
Maher, A. R., Arif, S., Madhani, M., Abozguia, K., Ahmed, I., Fernandez, B. O., Feelisch, M., O'Sullivan, A., Christopoulos, A., Sverdlov, A. L., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12152 · Cited by 26
“…is progressive failure of enzymatic bioactivation (Sage et al., 2000), and although the nature of the relevant nitrate reductase remains controversial (D’Souza et al., 2011), it is clear that GTN inhibits aldehyde dehydrogenases (ALDH; Towell et al., 1986; Chen et al., 2002; D’Souza et al., 2011).”
BackgroundVavra, A. K., Havelka, G. E., Martinez, J., Lee, V. R., Fu, B., Jiang, Q., Keefer, L. K., & Kibbe, M. R. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.04.013 · Cited by 24
Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia
Alef, M. J., Tzeng, E., & Zuckerbraun, B. S. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.014 · Cited by 20
Beutler, M., Harnischfeger, J., Weber, M. H. W., Hahnel, S. R., Quack, T., Blohm, A., Ueberall, M. E., Timm, T., Lochnit, G., Rennar, G. A., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115179 · Cited by 10
Metadata
- Authors
- Chen, Z., Zhang, J., & Stamler, J. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-06-04
- Volume
- 99
- Issue
- 12
- Pages
- 8306-8311
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2086629541
- Cited by
- 541
- References
- 42
- FWCI
- 21.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.